Literature DB >> 28459653

Pancreatic Pseudocyst Dilemma: Cumulative Multicenter Experience in Management Using Endoscopy, Laparoscopy, and Open Surgery.

Alaa A Redwan1, Mostafa A Hamad2, Mohammed A Omar3.   

Abstract

BACKGROUND: Pancreatic pseudocyst (PP) is the commonest cystic lesion of the pancreas. Internal drainage of PPs can be accomplished by traditional open or recently by minimally invasive laparoscopic or endoscopic approaches. We aimed to evaluate and compare the clinical outcomes after endoscopic, laparoscopic, and open drainage.
METHODS: Seventy-one patients with PP underwent endoscopic (n = 35), laparoscopic (n = 4), and open surgical drainage (n = 32). The primary outcome was the success rate. The secondary outcomes were the estimated blood loss, operative time, opioid requirement, morbidity and mortality, length of hospital stay, and recurrence rate.
RESULTS: The primary success rate was significantly higher for laparoscopic and open groups than for the endoscopic group, but the overall success rate was equivalent across the groups. There were no significant differences in the morbidity, mortality, requirement of blood transfusion, reinterventions, and recurrence rate between the groups. Endoscopic drainage revealed significantly lower blood loss, operative time, opioid requirement, and hospital stay in comparison to open and laparoscopic drainage.
CONCLUSION: Minimally invasive therapeutic techniques, whether endoscopic or laparoscopic for treatment of PP could be considered valuable, competitive, and promising alternatives for open surgery. Moreover, it is less invasive with less hospitalization and rapid return to work.

Entities:  

Keywords:  endoscopic; laparoscopic; open; pancreatic pseudocyst drainage

Mesh:

Year:  2017        PMID: 28459653     DOI: 10.1089/lap.2017.0006

Source DB:  PubMed          Journal:  J Laparoendosc Adv Surg Tech A        ISSN: 1092-6429            Impact factor:   1.878


  9 in total

Review 1.  Management of (Peri)Pancreatic Collections in Acute Pancreatitis.

Authors:  Mihailo Bezmarević; Sven M van Dijk; Rogier P Voermans; Hjalmar C van Santvoort; Marc G Besselink
Journal:  Visc Med       Date:  2019-04-02

Review 2.  A narrative review of the mechanism of acute pancreatitis and recent advances in its clinical management.

Authors:  Zhi Zheng; Yi-Xuan Ding; Yuan-Xu Qu; Feng Cao; Fei Li
Journal:  Am J Transl Res       Date:  2021-03-15       Impact factor: 4.060

Review 3.  [Interventional endoscopic treatment in acute pancreatitis].

Authors:  Marcus Hollenbach; Jürgen Feisthammel; Albrecht Hoffmeister
Journal:  Internist (Berl)       Date:  2021-09-21       Impact factor: 0.743

4.  Analysis of pancreatic pseudocyst drainage procedural outcomes: a population based study.

Authors:  Amrita Chawla; Faiz Afridi; Vishnu Prasath; Ravi Chokshi; Sushil Ahlawat
Journal:  Surg Endosc       Date:  2022-07-25       Impact factor: 3.453

Review 5.  Pancreatic pseudocyst: Dilemma of its recent management (Review).

Authors:  Jonathan Hartanto Tan; Wenjie Chin; Abdul Lateef Shaikh; Shusen Zheng
Journal:  Exp Ther Med       Date:  2020-12-18       Impact factor: 2.447

Review 6.  A narrative review of acute pancreatitis and its diagnosis, pathogenetic mechanism, and management.

Authors:  Zhi Zheng; Yi-Xuan Ding; Yuan-Xu Qu; Feng Cao; Fei Li
Journal:  Ann Transl Med       Date:  2021-01

7.  Laparoscopic Intervention to Pancreatic Pseudocyst Confers Short-Term Benefits: A Meta-Analysis.

Authors:  Yulin Guo; Shun Hu; Shuo Wang; Ang Li; Feng Cao; Fei Li
Journal:  Emerg Med Int       Date:  2021-11-17       Impact factor: 1.112

8.  Laparoscopic Cystogastrostomy in Children with Pancreatic Pseudocysts: A Preliminary Experience of Eight Cases.

Authors:  Vivek Samuel Gaikwad; Sundeep M C Kisku; Jujju Jacob Kurian; Tarun John K Jacob; John Mathai
Journal:  J Indian Assoc Pediatr Surg       Date:  2022-01-11

9.  Endoscopic Versus Laparoscopic Treatment for Pancreatic Pseudocysts: A Systematic Review and Meta-analysis.

Authors:  Wenzhen Hao; Yunli Chen; Yu Jiang; Aiming Yang
Journal:  Pancreas       Date:  2021-07-01       Impact factor: 3.327

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.